scholarly article | Q13442814 |
P819 | ADS bibcode | 2020NatCo..11.2358L |
P356 | DOI | 10.1038/S41467-020-16080-4 |
P932 | PMC publication ID | 7217877 |
P698 | PubMed publication ID | 32398649 |
P50 | author | Seung Hyun Kim | Q53176132 |
Hee-Jin Kim | Q59687975 | ||
Edward H Schuchman | Q92756224 | ||
Eunsoo Yu | Q94599567 | ||
P2093 | author name string | Ju Youn Lee | |
Im-Sook Song | |||
Seung Hoon Han | |||
Min Hee Park | |||
Min-Koo Choi | |||
Cheol-Min Park | |||
Hee Kyung Jin | |||
Jae-Sung Bae | |||
P2860 | cites work | NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice | Q24604235 |
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 | ||
Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases | Q27024102 | ||
Molecular basis of sphingosine kinase 1 substrate recognition and catalysis | Q27684446 | ||
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and -regulatory protein knockout mice | Q30407820 | ||
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease | Q30545790 | ||
Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. | Q30634663 | ||
Pro-resolving lipid mediators are leads for resolution physiology | Q30829097 | ||
Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes | Q33204916 | ||
Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids | Q33890830 | ||
Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease | Q33964297 | ||
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation | Q34157528 | ||
Proresolving lipid mediators and mechanisms in the resolution of acute inflammation | Q34411426 | ||
Resolution of inflammation is altered in Alzheimer's disease | Q34765889 | ||
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function | Q35172754 | ||
Microglial and macrophage polarization—new prospects for brain repair | Q35394922 | ||
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Q36376065 | ||
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma | Q36477818 | ||
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis | Q36777563 | ||
Exogenous C2 Ceramide Suppresses Matrix Metalloproteinase Gene Expression by Inhibiting ROS Production and MAPK Signaling Pathways in PMA-Stimulated Human Astroglioma Cells | Q36846961 | ||
ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression | Q37153606 | ||
C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells | Q37645459 | ||
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. | Q38200729 | ||
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation | Q38951466 | ||
Modulators of microglial activation and polarization after intracerebral haemorrhage | Q39317715 | ||
Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis | Q40664580 | ||
Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal Degeneration | Q41453886 | ||
The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages | Q41665336 | ||
Post-translational regulation of COX2 activity by FYN in prostate cancer cells | Q42847206 | ||
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases | Q47568641 | ||
Microglia emerge as central players in brain disease | Q47626576 | ||
Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum? | Q50229256 | ||
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models. | Q50531818 | ||
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. | Q50720019 | ||
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. | Q52584637 | ||
Neuropeptide Y Induces Hematopoietic Stem/Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity Through Y1 Receptor in Osteoblasts. | Q53119706 | ||
Microglia in Alzheimer's disease. | Q53392184 | ||
Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity | Q58105796 | ||
The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain. | Q64898882 | ||
A mechanistic hypothesis for the aspirin-induced switch in lipid mediator production by cyclooxygenase-2 | Q86980945 | ||
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα | Q89391648 | ||
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight | Q91114669 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 1 | |
P921 | main subject | Alzheimer's disease | Q11081 |
microglia | Q1622829 | ||
P304 | page(s) | 2358 | |
P577 | publication date | 2020-05-12 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease | |
P478 | volume | 11 |